HIGHLIGHTS
- who: Victor Mocanu from the Health policy, Compassionate use, Exemption, Psychedelics, Psilocybin, MDMA, Canada have published the paper: Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy, in the Journal: (JOURNAL)
- what: Despite the current challenges faced in accessing PAP, the growing body of evidence and evolving legal landscape both in Canada and internationally are causes for cautious optimism.
- future: Future directions for reintroducing and scaling PAP While a small number of Canadians obtained research exemptions to use MDMA for PAP in the recent positive PTSD trial and more research exemptions . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.